Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-005825
Filing Date
2025-04-29
Accepted
2025-04-29 16:05:21
Documents
20
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A chrs-20250611xdef14a.htm   iXBRL DEF 14A 980892
2 GRAPHIC chrs-20250611xdef14a_a001.jpg GRAPHIC 4936
3 GRAPHIC chrs-20250611xdef14a_a002.jpg GRAPHIC 51953
4 GRAPHIC chrs-20250611xdef14a_a003.jpg GRAPHIC 52537
5 GRAPHIC chrs-20250611xdef14a_bg001.jpg GRAPHIC 125124
6 GRAPHIC chrs-20250611xdef14a_bg002.jpg GRAPHIC 93432
  Complete submission text file 0001558370-25-005825.txt   2486819

Data Files

Seq Description Document Type Size
7 EX-101.SCH chrs-20250611.xsd EX-101.SCH 5983
8 EX-101.DEF chrs-20250611_def.xml EX-101.DEF 6957
9 EX-101.LAB chrs-20250611_lab.xml EX-101.LAB 14537
10 EX-101.PRE chrs-20250611_pre.xml EX-101.PRE 7515
22 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250611xdef14a_htm.xml XML 195312
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36721 | Film No.: 25887117
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)